Outcomes from Combined Chemoradiotherapy in Unresectable and Locally Advanced Resected Cholangiocarcinoma
- 30 October 2010
- journal article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 43 (1) , 50-55
Abstract
Whilst surgery is the only potentially curative treatment for cholangiocarcinoma, many patients are either unfit for major surgery or have unresectable disease. Patients who undergo attempted curative resective surgery often have involved resection margins. The role of radiotherapy in these settings has not been clarified and is often not considered because of fears of late complications, especially liver and gastrointestinal toxicity. We present our experience of treating cholangiocarcinoma, either unresectable or locally advanced, with conformal radiotherapy and concurrent chemotherapy, examining survival, toxicity, patterns of failure and details of radiotherapy and chemotherapy administered. Between 1995 and 2005, 20 patients, median age 60.5 years (range 45–78 years) with cholangiocarcinoma received radical conformal radiotherapy (median dose 46 Gy in 1.8–2.0 Gy fractions) with concurrent cisplatin/5-FU and sequential gemcitabine chemotherapy. Overall median survival was 20.4 months, 2 year survival, 43% and relapse-free survival, 9.6 months. 19/20 patients (95%) have died. One patient remains alive with liver and bone metastases. First site of failure was local and within radiotherapy field in 9/20 (45%) patients. No patient required interruption of radiotherapy for radiation toxicity, and none experienced subsequent late liver toxicity. The survival of this group of historically poor prognosis patients is encouraging. Durable local control was achieved in a majority of patients having chemoradiotherapy and toxicity was not severe. Although most patients still succumbed to disease, treatment delayed onset of progression. Conformal radiotherapy should be considered as an integral component in new investigative approaches to treatment in this rare cancer.Keywords
This publication has 20 references indexed in Scilit:
- External-beam radiotherapy for localized extrahepatic cholangiocarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- High-Dose-Rate Remote Afterloading Intracavitary Br achy therapy for the Treatment of Extrahepatic Biliary Duct CarcinomaThe Cancer Journal, 2002
- Staging, Resectability, and Outcome in 225 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2001
- Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United StatesHepatology, 2001
- External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerabilityRadiotherapy and Oncology, 1996
- Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- The impact of radiation dose in combined external beam and intraluminal IR-192 brachytherapy for bile duct cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Analysis of Failure After Curative Irradiation of Extrahepatic Bile Duct CarcinomaAnnals of Surgery, 1992
- The role of radiotherapy in the treatment of bile duct carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Definitive radiation therapy in bile duct carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988